Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 178

1.

Antibody landscapes after influenza virus infection or vaccination.

Fonville JM, Wilks SH, James SL, Fox A, Ventresca M, Aban M, Xue L, Jones TC, Le NMH, Pham QT, Tran ND, Wong Y, Mosterin A, Katzelnick LC, Labonte D, Le TT, van der Net G, Skepner E, Russell CA, Kaplan TD, Rimmelzwaan GF, Masurel N, de Jong JC, Palache A, Beyer WEP, Le QM, Nguyen TH, Wertheim HFL, Hurt AC, Osterhaus ADME, Barr IG, Fouchier RAM, Horby PW, Smith DJ.

Science. 2014 Nov 21;346(6212):996-1000. doi: 10.1126/science.1256427.

2.

Optimization of anti-virulence PqsR antagonists regarding aqueous solubility and biological properties resulting in new insights in structure-activity relationships.

Lu C, Kirsch B, Maurer CK, de Jong JC, Braunshausen A, Steinbach A, Hartmann RW.

Eur J Med Chem. 2014 May 22;79:173-83. doi: 10.1016/j.ejmech.2014.04.016. Epub 2014 Apr 5.

PMID:
24735643
3.

Benzamidobenzoic acids as potent PqsD inhibitors for the treatment of Pseudomonas aeruginosa infections.

Hinsberger S, de Jong JC, Groh M, Haupenthal J, Hartmann RW.

Eur J Med Chem. 2014 Apr 9;76:343-51. doi: 10.1016/j.ejmech.2014.02.014. Epub 2014 Feb 11.

PMID:
24589489
4.

Genomewide analysis of reassortment and evolution of human influenza A(H3N2) viruses circulating between 1968 and 2011.

Westgeest KB, Russell CA, Lin X, Spronken MI, Bestebroer TM, Bahl J, van Beek R, Skepner E, Halpin RA, de Jong JC, Rimmelzwaan GF, Osterhaus AD, Smith DJ, Wentworth DE, Fouchier RA, de Graaf M.

J Virol. 2014 Mar;88(5):2844-57. doi: 10.1128/JVI.02163-13. Epub 2013 Dec 26.

5.

Substitutions near the receptor binding site determine major antigenic change during influenza virus evolution.

Koel BF, Burke DF, Bestebroer TM, van der Vliet S, Zondag GC, Vervaet G, Skepner E, Lewis NS, Spronken MI, Russell CA, Eropkin MY, Hurt AC, Barr IG, de Jong JC, Rimmelzwaan GF, Osterhaus AD, Fouchier RA, Smith DJ.

Science. 2013 Nov 22;342(6161):976-9. doi: 10.1126/science.1244730.

6.

Designation of human adenovirus types based on sequence data: an unfinished debate.

Kajon AE, Echavarria M, de Jong JC.

J Clin Virol. 2013 Dec;58(4):743-4. doi: 10.1016/j.jcv.2013.10.014. Epub 2013 Oct 19. No abstract available.

PMID:
24210328
7.

Molecular and serological characterization of species B2 adenovirus strains isolated from children hospitalized with acute respiratory disease in Buenos Aires, Argentina.

Kajon AE, de Jong JC, Dickson LM, Arron G, Murtagh P, Viale D, Carballal G, Echavarria M.

J Clin Virol. 2013 Sep;58(1):4-10. doi: 10.1016/j.jcv.2013.06.030. Epub 2013 Jul 22.

PMID:
23886503
8.

Structure optimization of 2-benzamidobenzoic acids as PqsD inhibitors for Pseudomonas aeruginosa infections and elucidation of binding mode by SPR, STD NMR, and molecular docking.

Weidel E, de Jong JC, Brengel C, Storz MP, Braunshausen A, Negri M, Plaza A, Steinbach A, Müller R, Hartmann RW.

J Med Chem. 2013 Aug 8;56(15):6146-55. doi: 10.1021/jm4006302. Epub 2013 Jul 19.

PMID:
23834469
9.

Validation of PqsD as an anti-biofilm target in Pseudomonas aeruginosa by development of small-molecule inhibitors.

Storz MP, Maurer CK, Zimmer C, Wagner N, Brengel C, de Jong JC, Lucas S, Müsken M, Häussler S, Steinbach A, Hartmann RW.

J Am Chem Soc. 2012 Oct 3;134(39):16143-6. doi: 10.1021/ja3072397. Epub 2012 Sep 24.

PMID:
22992202
10.

Identification of small-molecule antagonists of the Pseudomonas aeruginosa transcriptional regulator PqsR: biophysically guided hit discovery and optimization.

Klein T, Henn C, de Jong JC, Zimmer C, Kirsch B, Maurer CK, Pistorius D, Müller R, Steinbach A, Hartmann RW.

ACS Chem Biol. 2012 Sep 21;7(9):1496-501. Epub 2012 Jul 5.

PMID:
22765028
11.

Genetic evolution of the neuraminidase of influenza A (H3N2) viruses from 1968 to 2009 and its correspondence to haemagglutinin evolution.

Westgeest KB, de Graaf M, Fourment M, Bestebroer TM, van Beek R, Spronken MI, de Jong JC, Rimmelzwaan GF, Russell CA, Osterhaus AD, Smith GJ, Smith DJ, Fouchier RA.

J Gen Virol. 2012 Sep;93(Pt 9):1996-2007. doi: 10.1099/vir.0.043059-0. Epub 2012 Jun 20.

12.

Discovery of antagonists of PqsR, a key player in 2-alkyl-4-quinolone-dependent quorum sensing in Pseudomonas aeruginosa.

Lu C, Kirsch B, Zimmer C, de Jong JC, Henn C, Maurer CK, Müsken M, Häussler S, Steinbach A, Hartmann RW.

Chem Biol. 2012 Mar 23;19(3):381-90. doi: 10.1016/j.chembiol.2012.01.015.

13.

[Influenza vaccination in the elderly makes sense. Many confounding factors in observational research].

de Jong JC, Hak E, Osterhaus AD.

Ned Tijdschr Geneeskd. 2010;154:A1171. Review. Dutch. No abstract available.

PMID:
20456794
14.

Influenza vaccine strain selection and recent studies on the global migration of seasonal influenza viruses.

Russell CA, Jones TC, Barr IG, Cox NJ, Garten RJ, Gregory V, Gust ID, Hampson AW, Hay AJ, Hurt AC, de Jong JC, Kelso A, Klimov AI, Kageyama T, Komadina N, Lapedes AS, Lin YP, Mosterin A, Obuchi M, Odagiri T, Osterhaus AD, Rimmelzwaan GF, Shaw MW, Skepner E, Stohr K, Tashiro M, Fouchier RA, Smith DJ.

Vaccine. 2008 Sep 12;26 Suppl 4:D31-4. Review.

PMID:
19230156
15.

[Influenza season 2007/'08 in the Netherlands: antigenic variation, oseltamivir resistance and vaccine composition for the 2008/'09 season].

Rimmelzwaan GF, de Jong JC, Donker GA, Meijer A, Fouchier RA, Osterhaus AD.

Ned Tijdschr Geneeskd. 2008 Sep 27;152(39):2138-44. Dutch.

PMID:
18856032
16.

[Registration of the first human vaccine against the highly pathogenic avian influenza A(H5N1) virus: considerations].

de Jong JC, Osterhaus AD.

Ned Tijdschr Geneeskd. 2008 Sep 27;152(39):2113-5. Dutch.

PMID:
18856026
18.

The global circulation of seasonal influenza A (H3N2) viruses.

Russell CA, Jones TC, Barr IG, Cox NJ, Garten RJ, Gregory V, Gust ID, Hampson AW, Hay AJ, Hurt AC, de Jong JC, Kelso A, Klimov AI, Kageyama T, Komadina N, Lapedes AS, Lin YP, Mosterin A, Obuchi M, Odagiri T, Osterhaus AD, Rimmelzwaan GF, Shaw MW, Skepner E, Stohr K, Tashiro M, Fouchier RA, Smith DJ.

Science. 2008 Apr 18;320(5874):340-6. doi: 10.1126/science.1154137.

19.

Human adenovirus type 52: a type 41 in disguise?

de Jong JC, Osterhaus AD, Jones MS, Harrach B.

J Virol. 2008 Apr;82(7):3809; author reply 3809-10. doi: 10.1128/JVI.02457-07. No abstract available.

20.

[New target populations for influenza vaccination; recommendations of the Health Council of the Netherlands].

de Jong JC.

Ned Tijdschr Geneeskd. 2007 Oct 27;151(43):2412. Dutch. No abstract available.

PMID:
18019222
21.

[The 2006/'07 influenza season in the Netherlands and the vaccine composition for the 2007/'08 season].

de Jong JC, Rimmelzwaan GF, Donker GA, Meijer A, Fouchier RA, Osterhaus AD.

Ned Tijdschr Geneeskd. 2007 Sep 29;151(39):2158-65. Dutch.

PMID:
17957994
22.
23.

[New target populations for influenza vaccination; recommendations of the Health Council of the Netherlands].

de Jong JC.

Ned Tijdschr Geneeskd. 2007 Sep 29;151(39):2140-2. Dutch.

PMID:
17957989
24.

Small molecule ago-allosteric modulators of the human glucagon-like peptide-1 (hGLP-1) receptor.

Teng M, Johnson MD, Thomas C, Kiel D, Lakis JN, Kercher T, Aytes S, Kostrowicki J, Bhumralkar D, Truesdale L, May J, Sidelman U, Kodra JT, Jørgensen AS, Olesen PH, de Jong JC, Madsen P, Behrens C, Pettersson I, Knudsen LB, Holst JJ, Lau J.

Bioorg Med Chem Lett. 2007 Oct 1;17(19):5472-8. Epub 2007 Jul 4.

PMID:
17827014
25.

Antigenic and genetic evolution of swine influenza A (H3N2) viruses in Europe.

de Jong JC, Smith DJ, Lapedes AS, Donatelli I, Campitelli L, Barigazzi G, Van Reeth K, Jones TC, Rimmelzwaan GF, Osterhaus AD, Fouchier RA.

J Virol. 2007 Apr;81(8):4315-22. Epub 2007 Feb 7.

26.

Small-molecule agonists for the glucagon-like peptide 1 receptor.

Knudsen LB, Kiel D, Teng M, Behrens C, Bhumralkar D, Kodra JT, Holst JJ, Jeppesen CB, Johnson MD, de Jong JC, Jorgensen AS, Kercher T, Kostrowicki J, Madsen P, Olesen PH, Petersen JS, Poulsen F, Sidelmann UG, Sturis J, Truesdale L, May J, Lau J.

Proc Natl Acad Sci U S A. 2007 Jan 16;104(3):937-42. Epub 2007 Jan 9.

27.

[The 2005-2006 influenza season in the Netherlands and the vaccine composition for the 2006-2007 season].

Rimmelzwaan GF, de Jong JC, Donker GA, Meijer A, Fouchier RA, Osterhaus AD.

Ned Tijdschr Geneeskd. 2006 Oct 7;150(40):2209-14. Dutch.

PMID:
17061434
28.

Circulation of incorrectly labeled adenovirus 50 and 51 prototype preparations.

de Jong JC, Niesters HG, van Doornum GJ.

J Clin Microbiol. 2006 Sep;44(9):3468. No abstract available.

29.

Seasonal influenza activity for 2005-2006 season seems to be ending in most European countries.

Paget WJ, Meijer A, Falcão JM, de Jong JC, Kyncl J, Meerhoff TJ, Meuwissen LE, Nicoll A, van der Velden J.

Euro Surveill. 2006 Apr 13;11(4):E060413.2. No abstract available. Erratum in: Euro Surveill. 2006 Apr;11(4):E060413.2.

PMID:
16809823
30.

Clinical influenza activity in Europe is still low, with influenza B virus being dominant: an update from EISS.

Meijer A, Falcão JM, de Jong JC, Kyncl J, Meerhoff TJ, Meuwissen LE, Nicoll A, van der Velden J, Paget WJ.

Euro Surveill. 2006 Feb 16;11(2):E060216.2. No abstract available. Erratum in: Euro Surveill. 2006;11(3):E060302.6. Euro Surveill. 2006 Feb;11(2):E060216.6.

PMID:
16804211
31.

[The influenza season 2004/'05 in the Netherlands with the largest epidemic of the last 5 years caused by the virus variant A/California and the composition of the vaccine for the season 2005/'06].

de Jong JC, Rimmelzwaan GF, Bartelds AI, Meijer A, Fouchier RA, Osterhaus AD.

Ned Tijdschr Geneeskd. 2005 Oct 15;149(42):2355-61. Dutch.

PMID:
16261717
32.

[The threatening influenza pandemic: a national store of oseltamivir is necessary].

de Jong JC, Osterhaus AD.

Ned Tijdschr Geneeskd. 2005 Jul 16;149(29):1618. Dutch.

PMID:
16078768
33.

Mutations, drift, and the influenza archipelago.

Smith DJ, Lapedes AS, de Jong JC, Bestebroer TM, Jones TC, Rimmelzwaan GF, Osterhaus AD, Fouchier RA.

Discov Med. 2004 Dec;4(24):371-7.

34.

[The 2003/2004 influenza season in the Netherlands with a limited epidemic of the virus variant A/Fujian, and the vaccine composition for the 2004/2005 season].

Rimmelzwaan GF, de Jong JC, Bartelds AI, Wilbrink B, Fouchier RA, Osterhaus AD.

Ned Tijdschr Geneeskd. 2004 Oct 2;148(40):1984-8. Dutch.

PMID:
15524136
35.

Mapping the antigenic and genetic evolution of influenza virus.

Smith DJ, Lapedes AS, de Jong JC, Bestebroer TM, Rimmelzwaan GF, Osterhaus AD, Fouchier RA.

Science. 2004 Jul 16;305(5682):371-6. Epub 2004 Jun 24.

36.

Effects of chemical chaperones on partially retarded NaCl cotransporter mutants associated with Gitelman's syndrome in a mouse cortical collecting duct cell line.

de Jong JC, Willems PH, Goossens M, Vandewalle A, van den Heuvel LP, Knoers NV, Bindels RJ.

Nephrol Dial Transplant. 2004 May;19(5):1069-76.

PMID:
15102966
37.

Haemagglutination-inhibiting antibody to influenza virus.

de Jong JC, Palache AM, Beyer WE, Rimmelzwaan GF, Boon AC, Osterhaus AD.

Dev Biol (Basel). 2003;115:63-73. Review.

PMID:
15088777
38.

A previously undescribed coronavirus associated with respiratory disease in humans.

Fouchier RA, Hartwig NG, Bestebroer TM, Niemeyer B, de Jong JC, Simon JH, Osterhaus AD.

Proc Natl Acad Sci U S A. 2004 Apr 20;101(16):6212-6. Epub 2004 Apr 8.

39.

Carbazates as potent inhibitors of hormone-sensitive lipase.

de Jong JC, Sørensen LG, Tornqvist H, Jacobsen P.

Bioorg Med Chem Lett. 2004 Apr 5;14(7):1741-4.

PMID:
15026062
40.

[Neuraminidase inhibitors oseltamivir and zanamivir: new means of defence against influenza].

de Jong JC, Beyer WE, Rimmelzwaan GF, Fouchier RA, Osterhaus AD.

Ned Tijdschr Geneeskd. 2004 Jan 10;148(2):73-9. Review. Dutch. Erratum in: Ned Tijdschr Geneeskd. 2004 Feb 14;148(7):348.

PMID:
14753128
41.

[The 2002/2003 influenza season in the Netherlands and the vaccine composition for the 2003/2004 season].

de Jong JC, Rimmelzwaan GF, Bartelds AI, Wilbrink B, Fouchier RA, Osterhaus AD.

Ned Tijdschr Geneeskd. 2003 Oct 4;147(40):1971-5. Dutch.

PMID:
14574782
42.

Functional expression of the human thiazide-sensitive NaCl cotransporter in Madin-Darby canine kidney cells.

de Jong JC, Willems PH, van den Heuvel LP, Knoers NV, Bindels RJ.

J Am Soc Nephrol. 2003 Oct;14(10):2428-35.

43.

[Avian influenza and oseltamivir; a retrospective view].

de Jong JC, Osterhaus AD.

Ned Tijdschr Geneeskd. 2003 Aug 23;147(34):1663. Dutch. No abstract available.

PMID:
12966635
44.

Combined use of SSRIs and NSAIDs increases the risk of gastrointestinal adverse effects.

de Jong JC, van den Berg PB, Tobi H, de Jong-van den Berg LT.

Br J Clin Pharmacol. 2003 Jun;55(6):591-5.

45.

Genetic renal disorders with hypomagnesemia and hypocalciuria.

Knoers NV, de Jong JC, Meij IC, Van Den Heuvel LP, Bindels RJ.

J Nephrol. 2003 Mar-Apr;16(2):293-6. Review.

PMID:
12768080
46.

Dominant isolated renal magnesium loss is caused by misrouting of the Na+,K+-ATPase gamma-subunit.

Meij IC, Koenderink JB, De Jong JC, De Pont JJ, Monnens LA, Van Den Heuvel LP, Knoers NV.

Ann N Y Acad Sci. 2003 Apr;986:437-43. Review.

PMID:
12763862
47.

The structural unit of the thiazide-sensitive NaCl cotransporter is a homodimer.

de Jong JC, Willems PH, Mooren FJ, van den Heuvel LP, Knoers NV, Bindels RJ.

J Biol Chem. 2003 Jul 4;278(27):24302-7. Epub 2003 Apr 18.

48.

[The 2001/2002 influenza season and the vaccine composition for the 2002/2003 season].

Rimmelzwaan GF, de Jong JC, Bartelds AI, Wilbrink B, Fouchier RA, Osterhaus AD.

Ned Tijdschr Geneeskd. 2002 Sep 28;146(39):1846-50. Dutch.

PMID:
12382372
49.

H5N1 influenza in Hong Kong: virus characterizations.

Osterhaus AD, de Jong JC, Rimmelzwaan GF, Claas EC.

Vaccine. 2002 May 15;20 Suppl 2:S82-3.

PMID:
12110266
50.

Functional expression of mutations in the human NaCl cotransporter: evidence for impaired routing mechanisms in Gitelman's syndrome.

De Jong JC, Van Der Vliet WA, Van Den Heuvel LP, Willems PH, Knoers NV, Bindels RJ.

J Am Soc Nephrol. 2002 Jun;13(6):1442-8.

Supplemental Content

Loading ...
Support Center